How health economic evaluation (HEE) contributes to decision-making in public health care: the case of Brazil.

Autor: Elias FT; Oswaldo Cruz Foundation, Brazil. Electronic address: flavia.tselias@gmail.com., Araújo DV; State University of Rio de Janeiro, Brazil.
Jazyk: angličtina
Zdroj: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen [Z Evid Fortbild Qual Gesundhwes] 2014; Vol. 108 (7), pp. 405-12. Date of Electronic Publication: 2014 Sep 20.
DOI: 10.1016/j.zefq.2014.08.021
Abstrakt: The universal access to a health care system for the Brazilian population was established in 1990. Brazil is a country with no tradition in the production and use of health economic evaluation (HEE) to guide decision making in the public health system. It is only within the last two decades that HEEs using a microeconomic approach have appeared in the academic field. On a national level, HEE and Health Technology Assessment (HTA), in a wider sense, were first taken into account in 2003. Two policies deserve to be mentioned - (i) the regulation of medicines in the Brazilian market, and (ii) science, technology and innovation policy. The latter required the fostering of applied research to encourage the application of methods which employ systematic reviews and economic analyses of cost-effectiveness to guide the incorporation of technologies in the Brazilian health care system. The Ministry of Health has initiated the process of incorporating these new technologies on a federal level during the last ten years. In spite of the improvement of HEE methods at Brazilian universities and research institutes, these technologies have not yet reached the governmental bodies. In Brazil, the main challenge lies in the production, interpretation and application of HEE to all technologies within the access scheme(s), and there is limited capacity building. Setting priorities can be the solution for Brazil to be able to perform HEE for relevant technologies within the access scheme(s) while the universal coverage system struggles with a triple burden of disease.
(Copyright © 2014. Published by Elsevier GmbH.)
Databáze: MEDLINE